Table 1.

Relationship between the Clinicopathological of DLBCL Patients and the SII Index

Patient Characteristics	SII Index				p-value
	SII < 1,210.615		SII ≥ 1,210.615
	n	%	n	%
Age
<60	36	38.30	25	26.60	0.8286
≥60	21	22.34	12	12.77
ECOG score†
< 2	53	56.38	32	34.04	0.3094
≥ 2	4	4.26	5	5.32
Sites†
< 2	51	54.26	33	35.11	1
≥ 2	6	6.38	4	4.26
LDH
Normal	21	22.34	7	7.45	0.104
Elevated	36	38.30	30	31.91
Stage
I & II	43	45.74	25	26.6	0.5502
III & IV	14	14.89	12	12.77
RDW (%)
≤ 14.355	31	32.98	18	19.15	0.7394
> 14.355	26	27.66	19	20.21
PLT (x 103 / μL)
< 315.5	37	39.36	8	8.51	9.88E-05
≥ 315.5	20	21.28	29	30.85
ANC (x 103 / μL)
< 5.29	43	45.74	8	8.51	9.35E-07
≥ 5.29	14	14.89	29	30.85
ALC (x 103 / μL)
< 1.59	13	13.83	27	28.72	4.38E-06
≥ 1.59	44	46.81	10	10.64
AMC (x 103 / μL)
≤ 0.625	30	31.91	22	23.4	0.6612
> 0.625	27	28.72	15	15.96
IPI†
Low Risk (0-1)	32	34.04	17	18.09	0.6063
Low-Intermediate Risk (2)	16	17.02	11	11.7
High-Intermediate Risk (3)	8	8.51	7	7.45
High Risk (4-5)	1	1.06	2	2.13
PLR
< 193.415	49	52.13	8	8.51	1.72E-09
≥ 193.415	8	8.51	29	30.85
NLR
< 3.425	50	53.19	5	5.32	4.53E-12
≥ 3.425	7	7.45	32	34.04
LMR
< 2.71	12	12.77	24	25.53	5.08E-05
≥ 2.71	45	47.87	13	13.83

†, Fisher Exact test